InNexus Biotechnology Retains The Investor Relations Group of New York
In: Business Wire, 2007-07-27
Zeitungsartikel
Zugriff:
BRITISH COLUMBIA, Canada -- InNexus Biotechnology Inc. (OTCBB:IXSBF) (TSX VENTURE:IXS), a drug development company commercializing the next generation of monoclonal antibodies based on its Dynamic Cross Linking (DXL[TM]) technology, has [...]
Titel: |
InNexus Biotechnology Retains The Investor Relations Group of New York
|
---|---|
Zeitschrift: | Business Wire, 2007-07-27 |
Veröffentlichung: | 2007 |
Medientyp: | Zeitungsartikel |
Schlagwort: |
|
Sonstiges: |
|